Brachytherapy
Volume 8, Issue 1 , Pages 40-44 , January 2009

Dosimetric guidance on using brachytherapy (low-dose-rate or high-dose-rate) to offset a flawed permanent prostate implant

  • Marco Zaider

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. Tel.: +1-212-639-7125.

Received 21 December 2007 ,Revised 22 August 2008 ,Accepted 6 October 2008.

References 

  1. Keyes M, Pickles T, Agranovich A, et al. 125-I reimplantation in patients with poor initial dosimetry after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;60:40–50
  2. Hughes L, Waterman FM, Dicker AP. Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate base. Brachytherapy. 2005;4:163–170
  3. Bice WS, Freeman JE, Russell LF, et al. Use of image coregistration in salvage prostate brachytherapy. Tech Urol. 2000;6:151–156
  4. Zaider M, Zelefsky MJ, Cohen GN, et al. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2005;61:702–713
  5. Zaider M, Minerbo GN. Tumour control probability: A formulation applicable to any temporal protocol of dose delivery. Phys Med Biol. 2000;45:279–293
  6. Hanin LG, Zaider M, Yakovlev AY. Distribution of the number of clonogens surviving fractionated radiotherapy: A long-standing problem revisited. Int J Radiat Biol. 2001;77:205–213
  7. Hanin LG. Iterated birth and death process as a model of radiation cell survival. Math Biosci. 2001;169:89–107
  8. Lea DE, Catcheside DG. The mechanism of the induction by radiation of chromosome aberrations in tradescantia. J Genet. 1942;44:216–245
  9. Kellerer AM, Rossi HH. Generalized formulation of dual radiation action 1197. Radiat Res. 1978;75:471–488
  10. Zaider, M, Dicello, J. RBEOER: A FORTRAN program for the computation of RBEs, OERs, survival ratios and the effects of fractionation using the theory of dual radiation action. Los Alamos Scientific Laboratory Report LA-7196-MS, 1–19. 1978.
  11. Wuu CS, Zaider M. A mathematical-description of sublethal damage repair and interaction during continuous low dose-rate irradiation. Radiat Prot Dosimetry. 1994;52:211–215
  12. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol. 1985;58:515–528
  13. Brenner DJ, Huang Y, Hall EJ. Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: Equivalent regimens for combined brachytherapy and external irradiation. Int J Radiat Oncol Biol Phys. 1991;21:1415–1423
  14. Brenner DJ, Hlatky LR, Hahnfeldt PJ, et al. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res. 1998;150:83–91
  15. Sachs RK, Hahnfeld P, Brenner DJ. The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol. 1997;72:351–374
  16. Zaider M, Zelefsky MJ, Hanin LG, et al. A survival model for fractionated radiotherapy with an application to prostate cancer. Phys Med Biol. 2001;46:2745–2758
  17. Blasko JC, Grimm PD, Sylvester JE, et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:839–850
  18. Grimm PD, Blasko JC, Sylvester JE, et al. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with I-125 brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31–40
  19. Haustermans K, Fowler JF. A comment on proliferation rates in human prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48:303
  20. Haustermans KMG, Hofland I, VanPoppel H, et al. Cell kinetic measurements in prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:1067–1070
  21. Li X, Wang JZ, Amin PP, et al. Using IMRT to repair unacceptable dose distributions of prostate implants. Int J Radiat Oncol Biol Phys. 2003;57(2, Suppl. 1):S434
  22. Zaider M, Hanin LG. On the question of biologically-equivalent dose and effective treatment time in permanent implants and fractionated treatments. Phys Med Biol. 2007;52:6355–6362
  23. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–694

PII: S1538-4721(08)00648-X

doi: 10.1016/j.brachy.2008.10.001

Brachytherapy
Volume 8, Issue 1 , Pages 40-44 , January 2009